| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 640 |
| 1 | INFLIXIMAB | 450 |
| 2 | UPADACITINIB | 305 |
| 3 | VEDOLIZUMAB | 275 |
| 4 | PREDNISONE | 252 |
| 5 | USTEKINUMAB | 209 |
| 6 | AZATHIOPRINE | 166 |
| 7 | METHOTREXATE SODIUM | 147 |
| 8 | METHOTREXATE | 124 |
| 9 | ADALIMUMAB-ADAZ | 93 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 7 | 0.0490 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 9 | 0.0364 |
| 2 | NIACINAMIDE, ZINC GLYCINATE, LEVOMEFOLATE CALCIUM, CUPRIC OXIDE, SELENIUM AND CHROMIUM | 1 | 0.0278 |
| 3 | MAGESIUM CITRATE | 1 | 0.0109 |
| 4 | METHENAMINE, SODIUM SALICYLATE | 1 | 0.0093 |
| 5 | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | 1 | 0.0090 |
| 6 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 7 | AZATHIOPRINE SODIUM | 13 | 0.0051 |
| 8 | PEGFILGRASTIM-APGF | 1 | 0.0051 |
| 9 | ADALIMUMAB-AFZB | 13 | 0.0048 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 610 |
| 1 | Interleukin-23 Antagonist [EPC] | 481 |
| 2 | Corticosteroid [EPC] | 369 |
| 3 | Janus Kinase Inhibitor [EPC] | 314 |
| 4 | Integrin Receptor Antagonist [EPC] | 291 |
| 5 | Interleukin-12 Antagonist [EPC] | 210 |
| 6 | Purine Antimetabolite [EPC] | 166 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 124 |
| 8 | Aminosalicylate [EPC] | 99 |
| 9 | Provitamin D2 Compound [EPC] | 85 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 1 | Interleukin-23 Antagonist [EPC] | 481 | 0.0046 |
| 2 | Integrin Receptor Antagonist [EPC] | 291 | 0.0033 |
| 3 | Macrolide Antibacterial [EPC] | 3 | 0.0030 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 6 | 0.0029 |
| 5 | Provitamin D2 Compound [EPC] | 85 | 0.0029 |
| 6 | Rifamycin Antimycobacterial [EPC] | 8 | 0.0023 |
| 7 | Interleukin-12 Antagonist [EPC] | 210 | 0.0020 |
| 8 | Janus Kinase Inhibitor [EPC] | 314 | 0.0020 |
| 9 | Purine Antimetabolite [EPC] | 166 | 0.0017 |